Drug policy experts and impacted communities from around the world express serious concerns about the preparations and already-drafted outcomes for the UN General Assembly Special Session (UNGASS) on the “world drug problem”.
With the 2016 UNGASS on drugs in one year, it is time to recognize the policy landscape is shifting while tensions within the UN drug control system continue to grow. A slowly increasing number of governments is expressing their frustrations with the current international drug control framework, particularly Mexico and Colombia, countries that are suffering from violence related to drug markets, are calling for reflection and analysis in order to consider new options, some of which include regulatory measures.
"There must be no new thinking and no new ideas." This statement is not necessarily one that you might expect from an intergovernmental forum on a hot topic of international policy - except perhaps when that policy is about drugs. This statement sadly, but also neatly, encapsulates the sense of frustration that I can often feel at the UN Commission on Narcotic Drugs (CND) - the annual meeting of the UN on all matters related to drug control, which took place last month in Vienna.
China is proposing there should be a worldwide ban on ketamine - the drug that can lead to users needing to have their bladders removed. But ketamine is used as an anaesthetic drug in much of Africa, and there are fears further international controls could affect medical usage too. The Chinese say that they are requesting the lowest level of restriction - known as schedule four - which would not affect its use for medical purposes. But Dr Kabwe in Lusaka's main hospital says any restriction will create a level of bureaucracy that will prohibit its use.
Scheduling ketamine would restrict its availability worldwide, which would lead to harmful impact on animal health and welfare, as well on public health. The World Medical Association is urging its 111 member associations to lobby their governments to oppose scheduling the anaesthetic agent Ketamine as a controlled drug.
The Commission on Narcotic Drugs (CND) in Vienna will decide next week between two opposite proposals by China and the WHO about international control of ketamine, an essential anaesthetic in human and veterinary medicine. China originally proposed bringing ketamine under the 1971 Convention’s most severe control regime of Schedule I, which would dramatically affect its availability for surgery in poor rural settings and emergency situations. The WHO Expert Committee reviewed all the evidence and advised against any international control of ketamine, arguing it would trigger a public health disaster.
The UN Commission considers to bring ketamine under the control of the 1971 Convention on Psychotropic Substances contrary to WHO recommendations. The 58th Session of the UN Commission on Narcotic Drugs (CND) in March 2015 has been asked to consider a Chinese proposal to place ketamine – an essential medicine used for anaesthesia – in Schedule I of the 1971 Convention (E/CN.7/2015/7 and E/CN.7/2015/81). Ketamine is the only available anaesthetic for essential surgery in most rural areas of developing countries, home to more than 2 billion of the world’s people. Scheduling ketamine under any of the 1971 treaty schedules will reduce its availability and further deepen the already acute crisis of global surgery.
UN’s International Narcotics Control Board (INCB) unprecedented condemnation of the use of death penalty for drug-related offences is welcome if long overdue. The bigger question is whether INCB’s consideration of human rights can be extended into a proper human rights and evidence-based examination of UN’s entire drug control regime.
An internal United Nations draft document leaked last weekend has offered outsiders a rare look at longstanding disagreements between member states over the course of U.N. drug policy. The document, first publicised by The Guardian and obtained by IPS, contains over 100 specific policy recommendations and proposals from member states, many at odds with the status quo on illicit drug eradication and prohibition.
Change is in the air ... But the pace could be quickened a bit. While the international policymaking body on drugs has long been stuck in neutral, there are signs that alternative voices are finally breaking through. This year's UN Commission on Narcotic Drugs featured some progress though its modest advances are only remarkable by comparison to a dismal past.
Ann Fordham of the International Drug Policy Consortium (IDPC) delivered the NGO Statement to CND Plenary under Item 8: Preparations for the high-level review of the implementation by Member States of the Political Declaration and Plan of Action on International Cooperation towards an integrated and balanced strategy to counter the world drug problem.
Over the past years, there have been some soft and hard defections on cannabis control. It is now time to discuss alternatives that are based on facts and evidence, said Dave Bewley Taylor introducing the session. TNI worked on a report on cannabis, which is looking at the hard defections in the United States and other types of cannabis regulation that have been happening around the world. The report also discusses how cannabis was included in the UN drug control conventions.
Tom Blickman, Hungarian Civil Liberties Union (HCLU)
28 March 2012
This year the Commission on Narcotic Drugs (CND) celebrated the 100th anniversary of the first international opium convention. What the UN drug czar said about these 100 years, is it a success story? Did NGO delegates agree with him? What is the significance of the speech Evo Morales, president of Bolivia made at the CND? What are the chances of the drug reform movement in Latin-America? What is the impact of CND resolutions in general? The HCLU's video advocacy team attended the CND and ask these burning questions. Watch the new movie to learn the answers from Yuri Fedotov, Gil Kerlikowske, Martin Jelsma, Damon Barret, Allen Clear and Mike Trace.
The last of the four ‘round tables’ of the high-level segment of the Commission on Narcotic Drugs was devoted to the broad issue of Countering illicit drug traffic and supply, and alternative development. TNI had been nominated by the Vienna NGO Committee to give a statement on the issue of Alternative Development (AD), being one of the few member NGOs with a track record on this issue and having actively participated in the Beyond 2008 initiative, including the negotiations at the July NGO forum to reach consensus on the text of a paragraph on AD in the final declaration. This is our impression of the event.
The first day at the Commission on Narcotic Drugs was marked by the announcement of President Evo Morales of Bolivia that he would start the process to remove the coca leaf from the 1961 Single Convention as well as the suspension of the paragraphs of that convention that prohibit the traditional chewing of coca leaf. Holding up a coca leaf in front of delegates at the UN summit on drugs he underlined his demand.
The Executive Director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, Michel Kazatchkine, urged the president of the UN Commission on Narcotic Drugs (CND) to send a strong message to the world with clear and specific language that calls for comprehensive harm reduction services.
The US delegation in Vienna continues to block any inclusion of harm reduction in the new Political Declaration – to be approved in March 2009 at the high-level segment of the 52nd session of the Commission on Narcotic Drugs. Three members of the US Congress have written a letter to the new US Ambassador to the UN, Susan Rice, to call for new instructions to be given to the delegation.